1. Home
  2. ATYR vs TCBS Comparison

ATYR vs TCBS Comparison

Compare ATYR & TCBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo aTyr Pharma Inc.

ATYR

aTyr Pharma Inc.

N/A

Current Price

$0.54

Market Cap

46.1M

Sector

Health Care

ML Signal

N/A

TCBS

Texas Community Bancshares Inc.

HOLD

Current Price

$17.83

Market Cap

48.5M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATYR
TCBS
Founded
2005
1934
Country
United States
United States
Employees
58
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
46.1M
48.5M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
ATYR
TCBS
Price
$0.54
$17.83
Analyst Decision
Hold
Analyst Count
9
0
Target Price
$3.67
N/A
AVG Volume (30 Days)
2.0M
4.7K
Earning Date
05-01-2026
04-24-2026
Dividend Yield
N/A
1.18%
EPS Growth
N/A
327.27
EPS
N/A
0.31
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$59.61
Revenue Growth
N/A
N/A
52 Week Low
$0.40
$15.10
52 Week High
$7.29
$20.00

Technical Indicators

Market Signals
Indicator
ATYR
TCBS
Relative Strength Index (RSI) 50.61 67.61
Support Level $0.42 $16.02
Resistance Level $0.59 $18.68
Average True Range (ATR) 0.04 0.32
MACD 0.02 0.12
Stochastic Oscillator 75.87 100.00

Price Performance

Historical Comparison
ATYR
TCBS

About ATYR aTyr Pharma Inc.

aTyr Pharma Inc is a clinical-stage biotechnology company focused on developing therapies for fibrosis and inflammatory conditions. Its research leverages tRNA synthetase biology to identify potential therapeutic targets. The company's discovery platform uses a proprietary library of domains derived from tRNA synthetases to explore signaling pathways. Its flagship clinical candidate, efzofitimod, is a novel biologic immunomodulatory in development for the treatment of interstitial lung disease (ILD).

About TCBS Texas Community Bancshares Inc.

Texas Community Bancshares Inc is a holding company. The company's business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations and borrowings from the Federal Home Loan Bank of Dallas, in residential real estate loans, commercial real estate loans, and, to a lesser extent, commercial loans, construction and land loans, and consumer and other loans. Its portfolio segments are real estate, agriculture, commercial, consumer, and other.

Share on Social Networks: